The Impact of Cancer Neuroscience on Novel Brain Cancer Treatment
Journal: Current Cancer Drug Targets
Guest editor(s):
Dr. Xiaofan Guo
Loma Linda University, Loma Linda, United States Of America
Co-Guest Editor(s):
Dr. Hao Xue
Shandong University, Jinan, China
,
Dr. Zhen Wang
Shanghai Institute of Microsystem and Information Technology, Shanghai, China
,
Dr. Shuai Wang
Qilu Hospital of Shandong University, Jinan, China
,
Dr. Yuan Pan
The University of Texas MD Anderson Cancer Center, Houston, United States of America
Submission closes on:
31st December, 2025
Introduction
Brain cancer remains one of the most challenging malignancies due to its complexity and resistance to conventional therapies. Recent advancements in cancer neuroscience have transformed our understanding of the brain's tumor microenvironment, offering promising insights into novel treatments. By studying the intricate interactions between cancer cells and the nervous system, researchers are uncovering pathways that lead to more effective, targeted therapies. This thematic issue is crucial, as it bridges the gap between neuroscience and oncology, potentially revolutionizing brain cancer treatment by improving patient outcomes, minimizing side effects, and overcoming therapeutic resistance.
Keywords
Targeted therapies, immunotherapy, neuromodulation, CRISPR, gene therapy, neuro-oncological surgery, Drug resistance, cancer stem cells, signaling pathways, adaptive resistance, neuroplasticity, Biomarkers, molecular imaging, MRI, PET scans, liquid biopsy, cancer diagnostics
Sub-topics
- Novel Therapeutic Approaches in Brain Cancer
- Cancer Neuroscience and Drug Resistance
- Neuroinflammation and Brain Cancer